Search - tctmd.com

Displaying 141 - 160 of 396

Sort: Relevancy | Date

Presentation TCT 2018

The Current Target Population for LAAC Closure Based on the Results of Clinical Trials in Europe

Presenter: Marek Grygier

September 22, 2018

Presentation TCT 2018

The Overview of Clinical Trials and Current Target Population for LAAC Closure

Presenter: Shephal Doshi

September 22, 2018

Presentation TCT 2018

Clinical Trials for Short DAPT: FDA Perspective

Presenter: Christopher J Popma

September 22, 2018

News Opinion Editor's Corner TCT 2018

TCT 2018, Day One: ‘Back to the Future’ With Stents, Stents, and More Stents

Shelley Wood

September 22, 2018

Presentation TCT 2018

The Case for TAVR in Low-Risk Patients: Rationale, Current Data, Clinical Trends, and Updates from the Ongoing Clinical Trials

Presenter: Allan Schwartz, Stephan Windecker, Jeffrey J. Popma

September 22, 2018

Presentation TCT 2018

Keystone TRIGUARD Cerebral Embolic Protection During TAVR: New Generation Devices and the Status of Ongoing Clinical Trials

Presenter: Alexandra J. Lansky, Axel Linke, Tamim Nazif

September 22, 2018

Presentation TCT 2018

Most Important Clinical Trials in Vascular Medicine and Intervention in the Past 10 Years

Presenter: Jay S. Giri, Sahil A. Parikh

September 22, 2018

News Conference News TCT 2018

EXCEL Deep Dive: Repeat Revascularization, Medical Therapy, and Anemia All Impact Patient Prognosis

Michael O'Riordan

September 21, 2018

News Opinion Off Script TCT 2018

Off Script: Welcome to the 30th TCT 2018 in Sunny San Diego

Kwan S. Lee

September 21, 2018

Presentation TCT 2018

TCT-120: Long-term Outcomes in Women and Men Following Percutaneous Coronary Intervention: An Individual Patient Data Pooled Analysis from 21 Randomized Trials

Presenter: Michael A. Kutcher, Tullio Palmerini, Ioanna Kosmidou

September 21, 2018

News Conference News TCT 2018

Untreated Accessory Arteries Dampen Renal Denervation Response: RADIANCE-HTN SOLO

Todd Neale

September 21, 2018

Presentation TCT 2018

TCT-92: Randomized Comparison of Ridaforolimus- and Zotarolimus-Eluting Coronary Stents: 2-Year Clinical Outcomes of the Pooled BIONICS and NIREUS Trials

Presenter: Alexandre Abizaid, Didier Carrié, David E. Kandzari

September 21, 2018

Presentation TCT 2018

Update of the NeoVas BRS Clinical Trials

Presenter: Runlin Gao, Martin B. Leon, Yaling Han

September 21, 2018

News Opinion Fellow Talk

What Not to Miss at TCT 2018 for Interventional Cardiology Fellows

Sahil Khera, MD, MPH

September 21, 2018

News Conference News TCT 2018

TCT 2018: Mitral Interventions, Stent Wars, Practical Skills, and More

Shelley Wood

September 17, 2018

News Daily News

TAVR Without Balloon Aortic Valvuloplasty: Increasingly Common, With Similar Outcomes

Yael L. Maxwell

September 17, 2018

News Daily News

Aspirin Falters Yet Again in Primary Prevention: ASPREE

Michael O'Riordan

September 17, 2018

News Conference News ESC 2018

My Takeaways From ESC 2018: Good or Bad, the Luxury of New Data Begets Cries for More

Shelley Wood

September 14, 2018

News Conference News PCR London Valves 2018

MITRA-FR in the Hot Seat as Experts Debate Impact on Guidelines and Practice

Shelley Wood

September 10, 2018

News Daily News

Pharmacist-Led BP Telemonitoring Intervention Works Up to 1 Year After Program Stops

Yael L. Maxwell

September 10, 2018

Advertisement

The Current Target Population for LAAC Closure Based on the Results of Clinical Trials in Europe

The Overview of Clinical Trials and Current Target Population for LAAC Closure

Clinical Trials for Short DAPT: FDA Perspective

TCT 2018, Day One: ‘Back to the Future’ With Stents, Stents, and More Stents

The Case for TAVR in Low-Risk Patients: Rationale, Current Data, Clinical Trends, and Updates from the Ongoing Clinical Trials

Keystone TRIGUARD Cerebral Embolic Protection During TAVR: New Generation Devices and the Status of Ongoing Clinical Trials

Most Important Clinical Trials in Vascular Medicine and Intervention in the Past 10 Years

EXCEL Deep Dive: Repeat Revascularization, Medical Therapy, and Anemia All Impact Patient Prognosis

Off Script: Welcome to the 30th TCT 2018 in Sunny San Diego

TCT-120: Long-term Outcomes in Women and Men Following Percutaneous Coronary Intervention: An Individual Patient Data Pooled Analysis from 21 Randomized Trials

Untreated Accessory Arteries Dampen Renal Denervation Response: RADIANCE-HTN SOLO

TCT-92: Randomized Comparison of Ridaforolimus- and Zotarolimus-Eluting Coronary Stents: 2-Year Clinical Outcomes of the Pooled BIONICS and NIREUS Trials

Update of the NeoVas BRS Clinical Trials

What Not to Miss at TCT 2018 for Interventional Cardiology Fellows

TCT 2018: Mitral Interventions, Stent Wars, Practical Skills, and More

TAVR Without Balloon Aortic Valvuloplasty: Increasingly Common, With Similar Outcomes

Aspirin Falters Yet Again in Primary Prevention: ASPREE

My Takeaways From ESC 2018: Good or Bad, the Luxury of New Data Begets Cries for More

MITRA-FR in the Hot Seat as Experts Debate Impact on Guidelines and Practice

Pharmacist-Led BP Telemonitoring Intervention Works Up to 1 Year After Program Stops

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content